Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol SERPIND1 contributors: - updated : 15-05-2006
HGNC name serine (or cysteine) proteinase inhibitor, clade D (heparin cofactor), member 1
HGNC id 4838
Corresponding disease
HCF2 thrombosis, recurrent
Location 22q11.21      Physical location : 21.128.382 - 21.142.008
Synonym name
  • heparin cofactor II
  • leuserpin 2
  • Synonym symbol(s) HC2, LS2, HCF2, HLS2, D22S673
    DNA
    TYPE functioning gene
    STRUCTURE 8.00 kb     4 Exon(s)
    10 Kb 5' upstream gene genomic sequence study
    MAPPING cloned Y linked N status confirmed
    Map cen - RANBP1 - USP18 - ZNF74 - PIK4CA /BCRL5 - SERPIND1 - SNAP29 - CRKL - LZTR1 - P2RXL2 - P2RXL1 - SLC7A4 - qter
    Authors Dunham (99)
    RNA
    TRANSCRIPTS type messenger
    EXPRESSION
    Type restricted
    constitutive of
       expressed in (based on citations)
    organ(s)
    SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
    Digestiveliver   predominantly
     mouthtongue   
    Endocrineparathyroid    
    Nervousbrain    
    cell lineage
    cell lines
    fluid/secretion plasma
    at STAGE
    PROTEIN
    PHYSICAL PROPERTIES
    STRUCTURE
    motifs/domains
  • an heparin binding site and a reactive site
  • N-terminal acidic repeat region mediating, in part, the glycosaminoglycan-accelerated thrombin inhibition
  • conjugated GlycoP
    HOMOLOGY
    intraspecies homolog to AT3
    Homologene
    FAMILY serpin family
    CATEGORY enzyme , regulatory
    SUBCELLULAR LOCALIZATION extracellular
        plasma membrane
    basic FUNCTION
  • inhibitor of thrombin and chymotrypsin
  • rapidly inhibiting thrombin in the presence of dermatan sulfate or heparin
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
    cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s) HCF2
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    constitutional   deletion    
    in di Georges syndrome
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
    ANIMAL & CELL MODELS